INTRODUCTION
Drug therapy can influence treatment planning and the provi sion of dental care by general dental practitioners. In addition, drug therapy can produce adverse effects on oral structure and function, for example lichenoid reactions and dry mouth. There is little information regarding the types of drug therapy taken by patients presenting to general dental practices for treatment in the United Kingdom. This information is not only essential for safe clinical practice but is also invaluable for planning undergraduate and postgraduate teaching in clinical pharmacology, and in monitoring future trends in therapeu tics. This study therefore investigated the drug therapy taken by patients attending general dental practices in the United Kingdom in 1995 and 2005.
METHOD
One hundred and ninety-nine consecutive patients attending a general dental practice in North Shields, Northumberland in 1995 and 500 consecutive patients attending a general den tal practice in Cleckheaton, West Yorkshire in 2005 were pro spectively questioned regarding their current medication at the time of presentation. The names of all current medications taken were obtained by direct questioning. The patient's gen eral medical practitioner was contacted if the patient's medica tion was unknown or unclear.
The medications were classified according to the British National Formulary 52. 1 The data obtained were compared to data reported by Hemsley in 1984. 2 Hemsley's paper reported data obtained from two general dental practices in Kent. Data analysis was performed using chi-square and Student's t tests. Table 2 shows the number of medi cations taken for each group. The number of medications taken is illustrated as a percentage in Figure 1 which shows that of those taking medications, the percentage taking three or more medications significantly increased from 1984 to 2005. Figure 2 and Table 3 show the number and percentage of the types of medication taken. The types of medication are expressed as a percentage of the total number of medications taken. An increase in the use of cardiovascular, endocrine and musculoskeletal medications is demonstrated. Compared to 1984, there are notable increases in the proportion tak ing nitrates and calcium channel blockers, anticoagulants, antiplatelet drugs, lipid regulators, bronchodilators and inhaled corticosteroids. There are notable decreases in the proportion taking hypnotics and anxiolytics, and contraceptives.
RESULTS

DISCUSSION
When comparing 1984 to 2005 the percentage of patients tak ing medications has increased, although there was a reduc tion in the proportion of patients taking prescribed drugs in the 1995 sample. There is an increasing trend toward poly pharmacy. There were statistically signifi cant increases in the proportion taking three or more medications in both 1995 and 2005 compared to 1984. Polypharmacy impacts on the provision of dental care, for example it has been demon strated that patients receiving multiple medications are more likely to suffer adverse effects when being treated under local anaesthesia. 3 There is a greater range of medications taken by patients in 2005. The changes in distribution of the type of therapy taken will clearly influence clinical practice: the increase in the proportion taking anticoagulants and antiplatelet drugs will affect procedures with significant risk of haemorrhage, such as exodontia. The increase in the proportion taking inhaled corticosteroids may lead to a greater number presenting with oral candidiasis. Increased therapy with cardiovascular drugs may lead to greater prevalence of oral side-effects such as dry mouth and lichenoid reactions. The changes in the distribution and the greater range of medications taken may be explained by the development of new medications and their introduction into clinical practice over time.
This study compares three geographically disparate popula tions, although there was no statistically signifi cant differ ence in the sex distribution between the three groups. The 1995 and 2005 groups showed a similar age distribution. The groups are therefore comparable in terms of age and sex but the geographically different populations may have differing health needs and different levels of health awareness. The prescribing habits of general medical practitioners and hos pital doctors may vary and also diagnostic capabilities may have improved with time, which again may have lead to inac curacy when comparing the groups. The smaller sample size in 1995 may have also contributed to inaccuracy. Lack of patients' willingness to volunteer information could also have lead to imprecision, as patients may not have wanted their dentist to know about the use of certain types of medication, such as contraceptives.
Haskell reported that knowledge of drugs of dental impor tance was imperative and suggested a limited number of medi cations that a general dental practitioner should be familiar with. 4 The number of medications that can affect oral health and affect the delivery of dental care is wide ranging. There fore knowledge of pharmacology should not be limited. 5 This study shows that more patients presenting to dental practices are taking medication now compared to 1984 and that there is an increasing trend toward polypharmacy. An increase in the number and range of medications taken increases the risk of drug interactions with medication that dentists may prescribe. 6, 7 Although beyond the scope of this paper, it is 3 . 3 L e u k o t r i e n e r e c e p t o r a n t a g o n i s t s 0 0 0 0 1 0 . 1 9 pertinent to point out that some drugs that dentists prescribe may produce severe adverse reactions when combined with concurrent medication -for example miconazole oral gel and metronidazole can dramatically increase the anticoagulant effect of warfarin. 8, 9 This can lead to haemorrhage. Awareness that such drug combinations should be avoided is essential for the safe practice of dentistry and illustrates the importance of an updated drug history. This study highlights the importance and relevance of teaching clinical pharmacology in the dental undergraduate curriculum. The need to maintain a contempo raneous knowledge of pharmacology and ready access to cur rent reference sources which list drug interactions (such as the British National Formulary 1 ), are essential to ensure the provision of safe dental care.
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